Brief: Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve Replacement
Wed 13:25
BRIEF-Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve Replacement Oct 28 (Reuters) - Abbott Laboratories ABT.N:
ABBOTT - RECEIVES FDA APPROVAL FOR FIRST DEVICE TO TREAT LEAKS AFTER HEART VALVE REPLACEMENT
Source text: [ID:]
Further company coverage: ABT.N
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Abbott Laboratories
See all newsPerrigo to sell infant formula business to MeridianMade for up to $175 million
Brief: Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve Disease
Corrected: German startup NVision shows new path to quantum computing chips in Nature paper
Brief: Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve Replacement
Brief: Catheter Precision Announces Publication Of Comparative Study Showing Locket Outperforms Abbott’S Perclose Internal Vascular Closure Device